Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Solaredge Technologies Inc

Start price
Target price
Perf. (%)
€219.00
18.06.21
€240.00
18.06.22
3.15%

Could be worthwhile Investment >10% per year
Sustainability is very important
Innovative
Some uniques
buy
Atoss Software AG

Start price
Target price
Perf. (%)
€177.60
18.06.21
€200.00
18.06.22
-0.90%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€413.70
18.06.21
€440.00
18.06.22
4.38%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
buy
Brenntag AG

Start price
Target price
Perf. (%)
€77.58
18.06.21
€85.00
18.06.22
2.94%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Standard Investments for future growth
Valuable balance sheet
Anheuser-Busch Inbev Inc.

Start price
Target price
Perf. (%)
€64.30
18.06.21
€58.00
18.06.22
-2.38%

Could be worthwhile Investment >10% per year
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€233.65
17.06.21
-
17.06.22
5.05%

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Fair valuation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.00
17.06.21
€60.00
17.06.22
5.21%

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
1.43%

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
-3.78%

Could be worthwhile Investment >10% per year
buy
Geci International

Start price
Target price
Perf. (%)
€0.015
17.06.21
-
17.06.22
-16.88%

Could be worthwhile Investment >10% per year
buy
Secureworks Corp

Start price
Target price
Perf. (%)
€17.40
17.06.21
€20.00
17.06.22
4.60%

Could be worthwhile Investment >10% per year
Innovative
Differentiated customer and product portfolio
Known brand
Piscines Desjoyaux

Start price
Target price
Perf. (%)
€27.90
17.06.21
€25.00
17.06.22
1.43%

Could be worthwhile Investment >10% per year
buy
NorCom Information Technology GmbH & Co. KGAA

Start price
Target price
Perf. (%)
€9.30
17.06.21
€100.00
17.06.24
4.30%

Could be very worthwhile Investment >20% year
buy
GlaxoSmithKline plc

Start price
Target price
Perf. (%)
€16.86
17.06.21
-
17.06.25
-1.54%

Small cyclical dependencies
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.93
17.06.21
€55.00
17.06.22
3.22%

Could be worthwhile Investment >10% per year
Innovative
Future proof or reliable business model
Higher risks for its business
Valneva SE

Start price
Target price
Perf. (%)
€10.89
11:07
€8.00
17.06.22
-0.55%

Could be worthwhile Investment >10% per year
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€20.60
17.06.21
€17.00
17.06.22
1.94%

Could be worthwhile Investment >10% per year
Sesen Bio Inc

Start price
Target price
Perf. (%)
€3.69
17.06.21
€2.50
17.06.22
-4.88%

Could be worthwhile Investment >10% per year
buy
Draftkings Inc.

Start price
Target price
Perf. (%)
€40.61
16.06.21
€49.00
16.06.22
5.09%

Revenue growth > 30% per year expected
Higher risks for its business
buy
BASF SE

Start price
Target price
Perf. (%)
€66.62
16.06.21
€75.00
16.06.22
-0.98%

Could be worthwhile Investment >10% per year
Good rating
Stable Large shareholder and/or long term investor
Higher risks for its business
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€159.00
13:52
€170.00
16.06.22
1.89%

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Spotify Technology SA

Start price
Target price
Perf. (%)
€200.30
16.06.21
€200.60
16.06.22
10.98%

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€46.95
16.06.21
€75.00
16.06.22
0.98%

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€488.40
15.06.21
-
15.06.22
5.24%

EBIT growth >5% per year expected
Very low/no dividend yield expected
buy
Hexagon Purus As

Start price
Target price
Perf. (%)
€3.28
15.06.21
€5.00
15.06.22
2.13%

Could be worthwhile Investment >10% per year